FOMAT

Digestive diseases

FOMAT Prime Therapeutic Areas provide highly specialized research sites with strong infrastructure, expert investigators, and proven recruitment models. In Digestive Diseases, we support trials across NAFLD, MASH, IBD, GERD, and related conditions with full diagnostic capabilities and access to diverse patients

Diverse patient
enrollment
0 %
Patients accessible
through EMR
0
Locations (sites and FQHCs) with full digestive trial capabilities
0
Advanced diagnostic technologies are fully integrated
0

Digestive diseases clinical trial capabilities

Our digestive clinical trial capabilities include fully equipped endoscopy and imaging facilities, experienced research teams, and tailored operational support across all phases. We ensure consistent trial delivery with access to diverse patient populations and specialized infrastructure

  • Full on-site diagnostic suite for digestive trials (Fibroscan, Colonoscopy, Capsule Endoscopy, Bravo pH Testing, MRE/MRI-PDFF, Liver Biopsy)
  • Dedicated SOPs and quality control processes for Digestive studies
  • Multi-location patient access across California clinical sites
  • Integrated EHR, CTMS, eSource, eConsent, and remote monitoring systems
  • Specialized community engagement and recruitment teams targeting metabolic populations
  • Experienced research teams trained in advanced metabolic protocols and complex clinical trial execution
Digestive Diseases | FOMAT

Key differentiators

Reliable start-up execution

Dedicated regulatory, contracting, and start-up teams streamline site activation and ensure predictable study launch timelines

Experienced digestive investigators

Board-certified investigators with extensive clinical research experience in NAFLD, MASH, IBD, GERD, and digestive disorders

Real-time data management

Integrated platforms (EHR, CTMS, eSource, eConsent) enable continuous data monitoring, query resolution, and sponsor access to clean, timely data

Comprehensive recruitment & retention

In-house patient engagement teams manage end-to-end recruitment, pre-screening, and retention processes across diverse digestive populations

Infrastructure for all study phases

Fully equipped clinical sites support early-phase through late-phase digestive trials with on-site diagnostics, imaging, and biospecimen capabilities